Seattle Genetics adds to senior management team
This article was originally published in Scrip
Seattle Genetics (US) has appointed Dr Elaine Waller senior vice-president of regulatory affairs and Christopher Pawlowicz senior vice-president of human resources. Dr Waller was previously with Sonus Pharmaceuticals, where she served as senior vice-president of regulatory affairs/quality assurance and clinical research, until its merger with OncoGenex Pharmaceuticals in August. Mr Pawlowicz was previously senior vice-president of human resources and administration at MedPointe Pharmaceuticals. Seattle Genetics has also promoted Dr Jonathan Drachman from senior medical director to vice-president of early clinical development.